Clinical Trials Browser

Not yet recruiting × Uterine Cervical Neoplasms × Head & Neck × Clear all

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07036211 2025-06-25

TREVINO

Not yet recruiting

700 enrolled

GynecologicHead & Neck

Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06519110 2024-07-25

CVL009-C2001

Phase 2 Not yet recruiting

60 enrolled

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Salivary Gland Neoplasms, Cholangiocarcinoma

NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Phase 1/2 Not yet recruiting

66 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06358053 2024-04-10

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Phase 1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT06297811 2024-03-07

Myeloprotection With Trilaciclib in Pan-cancer Population

Phase 2 Not yet recruiting

132 enrolled

BreastGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

Clinical Trials

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

TREVINO

CVL009-C2001

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Myeloprotection With Trilaciclib in Pan-cancer Population